Session Details
[2PS-16]【E】ASBMB-MBSJ joint symposium: Functional RNAs in development and disease
Thu. Nov 28, 2024 4:45 PM - 7:00 PM JST
Thu. Nov 28, 2024 7:45 AM - 10:00 AM UTC
Thu. Nov 28, 2024 7:45 AM - 10:00 AM UTC
Room 16(Marine Messe Fukuoka Hall B, 2F Meeting Room 2-1)
Organizer: Yuka Iwasaki (RIKEN), Noriko Saitoh (The Cancer Institute of JFCR)
RNA is a biomolecule capable of exhibiting a wide range of functions through its structure and/or modifications. This symposium, held in conjunction with the Australian Society for Biochemistry and Molecular Biology (ASBMB), will feature researchers from both Australia and Japan. They will introduce the mechanisms by which various properties of RNA contribute to the suppression of transposons, and transcriptional and epigenomic regulation in development, cancer, and neurological disorders. Through these latest studies, we aim to deepen the discussion on the potential of functional RNAs.
Introduction
[2PS-16-01]Targeting ribosomal RNA synthesis to treat cancer and bone marrow disorders
Nadine Hein1, Rita Ferreira1, Katherine Hannan1, Konstantin Panov2, Thejanni Udumanne1, Amee J George1, Zaka Yuen1, Perlita Poh1, Eric Kusnadi3, Alisee Huglo3, Mitchell Lawrence3, Mustapha Haddach4, Denis Drygin4, Luc Furic3, ○Ross Hannan1 (1. Australian National University, 2. Queen's University, Belfast, 3. Peter MacCallum Cancer Centre, 4. Pimera Therapeutics)
[2PS-16-03]The RNA demethylase FTO suppresses DNA repair by inhibiting PARP1
○Jocelyn Widagdo1 (1. Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Australia)
[2PS-16-05]4.5SH functions as a natural therapeutic noncoding RNA that induce skipping of deleterious exons
○Shinichi Nakagawa1 (1. Hokkaido University)
[2PS-16-06]Small RNA-mediated regulation of transposons in germline development
○Yuka W. Iwasaki1 (1. RIKEN, IMS)